Full Press Release Details
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference.
IRON
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Key Takeaway: Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
Price reaction · baseline $28.1 (2023-04-20 close) · hit after-hours · clean, no other IRON news in the window
day 0 close
+11.6%
day 1
+6.2%
day 3 · peak
+12.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)